NUAK1 and neoplasm: Our comparative analysis of NUAK1 expression levels with relevant clinic-pathologic measures of metastatic spread and patient tumor burden, as well as in vitro cell migratory analyses in chemo-sensitive and -resistant models of ovarian cancer cells, confirms previous findings implicating NUAK1 as a key factor supporting invasive and metastatic characteristics of tumor cells.